Uso de ranolazina en paciente con síndrome de Timothy tipo 2

Uso de ranolazina en paciente con síndrome de Timothy tipo 2

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Revista española de cardiologia 2022-05, Vol.75 (5), p.447-448
Hauptverfasser: Hermida, Alexis, Jedraszak, Guillaume, Kubala, Maciej, Bourgain, Marion, Bodeau, Sandra, Hermida, Jean-Sylvain
Format: Artikel
Sprache:eng
Schlagworte:
Human health and pathology
Life Sciences
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 448
container_issue 5
container_start_page 447
container_title Revista española de cardiologia
container_volume 75
creator Hermida, Alexis
Jedraszak, Guillaume
Kubala, Maciej
Bourgain, Marion
Bodeau, Sandra
Hermida, Jean-Sylvain
description
doi_str_mv 10.1016/j.recesp.2021.10.023
format Article
fullrecord <record><control><sourceid>hal</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_04010417v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>oai_HAL_hal_04010417v1</sourcerecordid><originalsourceid>FETCH-LOGICAL-h803-c3115174f9d9a16757c7eb7fe99e4efc0358a9e78ca891d3bbd6a64b127e5c893</originalsourceid><addsrcrecordid>eNotjsFKxDAURYMoWEf_wEW2LlrfS9KmWbgYBnWEgpu6Lmn6Sju0SWmLMP6TX-GPOYOuDhwOl8vYPUKCgNnjIZnJ0TIlAgSeVAJCXrAIU21iIZS4ZBFIgDg3Ulyzm2U5AIhUKhWxp48l8Ib4bH0Y7FfvLSfPJ-t68itxFzxffr59M4eRzl3Zj2Htjnztp8DFLbtq7bDQ3T83rHx5Lnf7uHh_fdtti7jLQcZOIqaoVWsaYzHTqXaaat2SMaSodSDT3BrSubO5wUbWdZPZTNUoNKXudHrDHv5mOztU09yPdj5WwfbVfltUZwcKEBTqT5S_apxNsA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Uso de ranolazina en paciente con síndrome de Timothy tipo 2</title><source>Elsevier ScienceDirect Journals Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Hermida, Alexis ; Jedraszak, Guillaume ; Kubala, Maciej ; Bourgain, Marion ; Bodeau, Sandra ; Hermida, Jean-Sylvain</creator><creatorcontrib>Hermida, Alexis ; Jedraszak, Guillaume ; Kubala, Maciej ; Bourgain, Marion ; Bodeau, Sandra ; Hermida, Jean-Sylvain</creatorcontrib><identifier>ISSN: 0300-8932</identifier><identifier>EISSN: 1579-2242</identifier><identifier>DOI: 10.1016/j.recesp.2021.10.023</identifier><language>eng</language><publisher>Elsevier España</publisher><subject>Human health and pathology ; Life Sciences</subject><ispartof>Revista española de cardiologia, 2022-05, Vol.75 (5), p.447-448</ispartof><rights>Attribution - NonCommercial</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-5704-6830 ; 0000-0002-7343-9212 ; 0000-0001-9276-2886 ; 0000-0003-2392-3759</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://u-picardie.hal.science/hal-04010417$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Hermida, Alexis</creatorcontrib><creatorcontrib>Jedraszak, Guillaume</creatorcontrib><creatorcontrib>Kubala, Maciej</creatorcontrib><creatorcontrib>Bourgain, Marion</creatorcontrib><creatorcontrib>Bodeau, Sandra</creatorcontrib><creatorcontrib>Hermida, Jean-Sylvain</creatorcontrib><title>Uso de ranolazina en paciente con síndrome de Timothy tipo 2</title><title>Revista española de cardiologia</title><subject>Human health and pathology</subject><subject>Life Sciences</subject><issn>0300-8932</issn><issn>1579-2242</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNotjsFKxDAURYMoWEf_wEW2LlrfS9KmWbgYBnWEgpu6Lmn6Sju0SWmLMP6TX-GPOYOuDhwOl8vYPUKCgNnjIZnJ0TIlAgSeVAJCXrAIU21iIZS4ZBFIgDg3Ulyzm2U5AIhUKhWxp48l8Ib4bH0Y7FfvLSfPJ-t68itxFzxffr59M4eRzl3Zj2Htjnztp8DFLbtq7bDQ3T83rHx5Lnf7uHh_fdtti7jLQcZOIqaoVWsaYzHTqXaaat2SMaSodSDT3BrSubO5wUbWdZPZTNUoNKXudHrDHv5mOztU09yPdj5WwfbVfltUZwcKEBTqT5S_apxNsA</recordid><startdate>202205</startdate><enddate>202205</enddate><creator>Hermida, Alexis</creator><creator>Jedraszak, Guillaume</creator><creator>Kubala, Maciej</creator><creator>Bourgain, Marion</creator><creator>Bodeau, Sandra</creator><creator>Hermida, Jean-Sylvain</creator><general>Elsevier España</general><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0002-5704-6830</orcidid><orcidid>https://orcid.org/0000-0002-7343-9212</orcidid><orcidid>https://orcid.org/0000-0001-9276-2886</orcidid><orcidid>https://orcid.org/0000-0003-2392-3759</orcidid></search><sort><creationdate>202205</creationdate><title>Uso de ranolazina en paciente con síndrome de Timothy tipo 2</title><author>Hermida, Alexis ; Jedraszak, Guillaume ; Kubala, Maciej ; Bourgain, Marion ; Bodeau, Sandra ; Hermida, Jean-Sylvain</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h803-c3115174f9d9a16757c7eb7fe99e4efc0358a9e78ca891d3bbd6a64b127e5c893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Human health and pathology</topic><topic>Life Sciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hermida, Alexis</creatorcontrib><creatorcontrib>Jedraszak, Guillaume</creatorcontrib><creatorcontrib>Kubala, Maciej</creatorcontrib><creatorcontrib>Bourgain, Marion</creatorcontrib><creatorcontrib>Bodeau, Sandra</creatorcontrib><creatorcontrib>Hermida, Jean-Sylvain</creatorcontrib><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>Revista española de cardiologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hermida, Alexis</au><au>Jedraszak, Guillaume</au><au>Kubala, Maciej</au><au>Bourgain, Marion</au><au>Bodeau, Sandra</au><au>Hermida, Jean-Sylvain</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Uso de ranolazina en paciente con síndrome de Timothy tipo 2</atitle><jtitle>Revista española de cardiologia</jtitle><date>2022-05</date><risdate>2022</risdate><volume>75</volume><issue>5</issue><spage>447</spage><epage>448</epage><pages>447-448</pages><issn>0300-8932</issn><eissn>1579-2242</eissn><pub>Elsevier España</pub><doi>10.1016/j.recesp.2021.10.023</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-5704-6830</orcidid><orcidid>https://orcid.org/0000-0002-7343-9212</orcidid><orcidid>https://orcid.org/0000-0001-9276-2886</orcidid><orcidid>https://orcid.org/0000-0003-2392-3759</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0300-8932
ispartof Revista española de cardiologia, 2022-05, Vol.75 (5), p.447-448
issn 0300-8932
1579-2242
language eng
recordid cdi_hal_primary_oai_HAL_hal_04010417v1
source Elsevier ScienceDirect Journals Complete; EZB-FREE-00999 freely available EZB journals
subjects Human health and pathology
Life Sciences
title Uso de ranolazina en paciente con síndrome de Timothy tipo 2
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T11%3A09%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-hal&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Uso%20de%20ranolazina%20en%20paciente%20con%20s%C3%ADndrome%20de%20Timothy%20tipo%202&rft.jtitle=Revista%20espa%C3%B1ola%20de%20cardiologia&rft.au=Hermida,%20Alexis&rft.date=2022-05&rft.volume=75&rft.issue=5&rft.spage=447&rft.epage=448&rft.pages=447-448&rft.issn=0300-8932&rft.eissn=1579-2242&rft_id=info:doi/10.1016/j.recesp.2021.10.023&rft_dat=%3Chal%3Eoai_HAL_hal_04010417v1%3C/hal%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true